JNJ vs CVS
By Alex · Tickerpine
Johnson & Johnson vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CVS |
|---|---|---|
| Price | $285.75 | $89.35 |
| Market cap | $687.89B | $114.32B |
| P/E ratio | 43.4 | 10.4 |
| ROE | 20.02% | 14.36% |
| Profit margin | 16.20% | 2.64% |
| Revenue growth | 5.90% | 5.40% |
| Dividend yield | 1.88% | 2.98% |
| Beta | 0.20 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CVS in plain English
- JNJ is the bigger company — about 6.0× the market cap of CVS.
- CVS is cheaper on earnings (P/E 10.4 vs 43.4).
- JNJ earns a higher return on equity (20% vs 14%).
- JNJ is growing revenue faster (6% vs 5%).
- CVS has the higher dividend yield (2.98% vs 1.88%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.